Showing results (281-290 of 317) with videos related to

Sort By:
Pageof 32
The New England Journal of Medicine|October 14, 2011
Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosisLuca Richeldi, Ulrich Costabel, Moises Selman, et al.
Science Signaling|March 25, 2025
A lupus-derived autoantibody that binds to intracellular RNA activates cGAS-mediated tumor immunity and can deliver RNA into cellsXiaoyong Chen, Xiangjun Tang, Ying Xie, et al.
Cancer Research|May 9, 2019
Upregulation of Scavenger Receptor B1 Is Required for Steroidogenic and Nonsteroidogenic Cholesterol Metabolism in Prostate CancerJacob A Gordon, Jake W Noble, Ankur Midha, et al.
The Lancet. Respiratory Medicine|February 8, 2018
Time for a change: is idiopathic pulmonary fibrosis still idiopathic and only fibrotic?Paul J Wolters, Timothy S Blackwell, Oliver Eickelberg, et al.
The Lancet. Respiratory Medicine|November 24, 2016
Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosisSteven D Nathan, Carlo Albera, Williamson Z Bradford, et al.
Nature Medicine|October 26, 2005
Regulation of lung injury and repair by Toll-like receptors and hyaluronanDianhua Jiang, Jiurong Liang, Juan Fan, et al.
Chest|April 10, 2015
Sensitivity Analyses of the Change in FVC in a Phase 3 Trial of Pirfenidone for Idiopathic Pulmonary FibrosisDavid J Lederer, Williamson Z Bradford, Elizabeth A Fagan, et al.
The Journal of Experimental Medicine|January 14, 2015
Blocking follistatin-like 1 attenuates bleomycin-induced pulmonary fibrosis in miceYingying Dong, Yan Geng, Lian Li, et al.
The Journal of Experimental Medicine|August 18, 2022
HER2 drives lung fibrosis by activating a metastatic cancer signature in invasive lung fibroblastsXue Liu, Yan Geng, Jiurong Liang, et al.
The Journal of Clinical Investigation|April 7, 2022
The ZIP8/SIRT1 axis regulates alveolar progenitor cell renewal in aging and idiopathic pulmonary fibrosisJiurong Liang, Guanling Huang, Xue Liu, et al.
Pageof 32